This content is machine translated Chronic spontaneous urticaria When antihistamines are not enough – ligelizumab soon available in addition to omalizumab? The biologic omalizumab has empirically well-documented efficacy and safety and is considered the treatment of choice in international guidelines for cases of chronic spontaneous urticaria with inadequate response to antihistamines.…
View Post 6 min This content is machine translated Thrombosis risk with the pill Which pill should you prescribe? After the death of a young girl who died of a pulmonary embolism, many are asking: How safe is the pill? The conclusion: the absolute risk is low, the combined…
